Dr. Viraj Lavingia

Introduction

Expertise

• Dr. Viraj Lavingia holds a special interest in GI Oncology, especially colorectal cancers and pancreaticobiliary cancers.
• He has so far handled more than 5000 cases.

Recognition

• Dr. Viraj won a scholarship award (UICC fellowship from City of Hope, Duarte USA, June 2016) for the project “HAI (Hepatic Arterial Infusion) chemotherapy for liver-limited metastatic colorectal cancer”.
• He is a trained and certified member of the European Society for Medical Oncology & the American Society of Clinical Oncology.

Publications

• Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma—2 case reports and a brief review. (2016) Journal of gastrointestinal oncology, 7(6), E98.
• Systemic treatment for metastatic colorectal cancer in the era of precision medicine (Journal of Surgical Oncology 2019-04).
• Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma—2 case reports and a brief review (Journal of Gastrointestinal Oncology 2016-12).
• Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma on Sunitinib (Indian Journal of Cancer 2016).
• PRES, the most uncommon side effect of one of the commonest chemotherapy regimen, FOLFOX (Apollo Medicine 2015-03).

Other Doctors